NCT05597657View on ClinicalTrials.gov

Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

September 15, 2023

Study Completion Date

September 15, 2023

Conditions
Cardiac Magnetic ResonanceT1 MappingHealthy Individuals
Interventions
OTHER

Fluid administration (Fresenius Kabi Sodium Chloride 0.9%)

All participants in substudy 2 will be administered 2 liters of isotonic saline infusion (Fresenius Kabi Sodium Chloride 0.9%) intravenously. CMR and echocardiography will be performed before and after infusion.

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Danish Cardiovascular Academy (DCA)

UNKNOWN

collaborator

Eva og Henry Frænkels Mindefond

OTHER

collaborator

Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT05597657 - Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals | Biotech Hunter | Biotech Hunter